Clinical Lab 2.0: A Value-Based Care Diagnostic Business Model with Alternative Payment Frameworks for Population Health
Mar 25, 2026
Clinical laboratories are facing significant economic pressure as the Protecting Access to Medicare Act (PAMA) driven reimbursement cuts erode margins and fee-for-service models become unsustainable. At the same time, nearly half of U.S. healthcare payments now flow through value-based arrangements, creating a pivotal opportunity for laboratories to realign with this new paradigm. This paper outlines…
Framing the Movement: Transforming from Reactive Confirmation to Proactive Prediction
Feb 25, 2026
An Architectural Framework for Healthcare Transformation Through Laboratory Medicine The transformation of laboratory medicine from reactive diagnostic confirmation to proactive disease prediction represents a fundamental restructuring. This paper proposes an architectural framework, defined as Framing the Movement, that proposes Clinical Lab 2.0 not as incremental healthcare reform but as a systematic architectural redesign. Drawing upon…
Enhancing Value-Based Care Through Laboratory-Assisted Identification of Care Gaps
Nov 12, 2025
The shift from fee-for-service to value-based care is transforming the role of clinical laboratories. Instead of being transactional providers of test results, the most forward-looking aim for laboratorians is to serve as strategic drivers of patient and population health. This idea is at the core of the Clinical Lab 2.0 movement , , which emphasizes…
The Future of Clinical Laboratories in Value-based Care—Is this our tomorrow to lose?
May 21, 2025
The transition to value-based health care, emphasizing quality outcomes over service volume, presents challenges and opportunities for pathologists and clinical laboratorians. To remain relevant in this evolving landscape, lab professionals must adapt their roles and focus on delivering value. Others are seizing this opportunity. Laboratories risk being left not as an asset for driving the…